Praxis Market Capitalization from 2010 to 2024
| PRAX Stock | USD 71.14 3.99 5.31% |
Check Praxis Precision financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Praxis Precision's main balance sheet or income statement drivers, such as Net Interest Income of 109.3 K, Interest Income of 155.8 K or Depreciation And Amortization of 240.9 K, as well as many indicators such as Price To Sales Ratio of 48.03, Dividend Yield of 0.0 or PTB Ratio of 1.62. Praxis financial statements analysis is a perfect complement when working with Praxis Precision Valuation or Volatility modules.
Praxis | Market Capitalization |
Latest Praxis Precision's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Praxis Precision Medicines over the last few years. It is Praxis Precision's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Praxis Precision's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.4 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Praxis Market Capitalization Regression Statistics
| Arithmetic Mean | 403,854,132 | |
| Geometric Mean | 357,669,594 | |
| Coefficient Of Variation | 38.70 | |
| Mean Deviation | 129,922,314 | |
| Median | 492,437,528 | |
| Standard Deviation | 156,311,295 | |
| Sample Variance | 24433.2T | |
| Range | 382.7M | |
| R-Value | (0.72) | |
| Mean Square Error | 12688.7T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (25,150,361) | |
| Total Sum of Squares | 342065.1T |
Praxis Market Capitalization History
About Praxis Precision Financial Statements
Praxis Precision investors use historical fundamental indicators, such as Praxis Precision's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Praxis Precision. Please read more on our technical analysis and fundamental analysis pages.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.